Valeant becomes Bausch Health Companies

Valeant Pharmaceuticals, the Canadian-based company that took over Bausch + Lomb five years ago with a total investment of $8.3 billion, will change its name next month to Bausch Health Companies, with a new corporate brand identity, new imagery, a new website and a new stock market ticker, BHC.

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.